Barbiturate use among migraine patients significantly decreased after initiating treatment with rimegepant, a calcitonin gene-related peptide (CGRP) antagonist used for migraine treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback